The ANSWER study reported that long-term albumin administration to patients with cirrhosis and uncomplicated ascites improves survival. Such treatment led serum albumin to increase within a month, remaining stable thereafter. This post-hoc analysis aimed at determining whether on-treatment serum albumin could guide therapy.
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites / Caraceni, Paolo; Tufoni, Manuel; Zaccherini, Giacomo; Riggio, Oliviero; Angeli, Paolo; Alessandria, Carlo; Neri, Sergio; Foschi, Francesco G; Levantesi, Fabio; Airoldi, Aldo; Simone, Loredana; Svegliati-Baroni, Gianluca; Fagiuoli, Stefano; Laffi, Giacomo; Cozzolongo, Raffaele; Di Marco, Vito; Sangiovanni, Vincenzo; Morisco, Filomena; Toniutto, Pierluigi; Gasbarrini, Antonio; De Marco, Rosanna; Piano, Salvatore; Nardelli, Silvia; Elia, Chiara; Roncadori, Andrea; Baldassarre, Maurizio; Bernardi, Mauro. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - ELETTRONICO. - 24:(2020), pp. Online ahead of print.-Online ahead of print.. [10.1016/j.jhep.2020.08.021]
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
Laffi, Giacomo
Membro del Collaboration Group
;
2020
Abstract
The ANSWER study reported that long-term albumin administration to patients with cirrhosis and uncomplicated ascites improves survival. Such treatment led serum albumin to increase within a month, remaining stable thereafter. This post-hoc analysis aimed at determining whether on-treatment serum albumin could guide therapy.File | Dimensione | Formato | |
---|---|---|---|
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites Elsevier Enhanced Reader.htm
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
169.02 kB
Formato
HTML
|
169.02 kB | HTML |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.